# Tyra Biosciences, Inc. (TYRA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Tyra Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TYRA/mda/fy2025/): filed 2026-03-02; accession 0001193125-26-085490 (https://www.sec.gov/Archives/edgar/data/1863127/000119312526085490/tyra-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TYRA/mda/fy2024/): filed 2025-03-27; accession 0000950170-25-046124 (https://www.sec.gov/Archives/edgar/data/1863127/000095017025046124/tyra-20241231.htm)
- [FY 2023 MD&A](/company/TYRA/mda/fy2023/): filed 2024-03-19; accession 0000950170-24-033461 (https://www.sec.gov/Archives/edgar/data/1863127/000095017024033461/tyra-20231231.htm)
- [FY 2022 MD&A](/company/TYRA/mda/fy2022/): filed 2023-03-22; accession 0000950170-23-009181 (https://www.sec.gov/Archives/edgar/data/1863127/000095017023009181/tyra-20221231.htm)
- [FY 2021 MD&A](/company/TYRA/mda/fy2021/): filed 2022-03-03; accession 0000950170-22-002814 (https://www.sec.gov/Archives/edgar/data/1863127/000095017022002814/tyra-20211231.htm)

Back to /company/TYRA/